key: cord-0741612-oqhnkioo authors: Scott, S.; Cook, K.; Barley, K. title: Postlockdown Dynamics of COVID-19 in New York, Florida, Arizona, and Wisconsin date: 2021-01-04 journal: nan DOI: 10.1101/2020.12.28.20248967 sha: 66e7e41a9730b7452172236828ab8c9249245776 doc_id: 741612 cord_uid: oqhnkioo The COVID-19 pandemic is widely studied as it continues to threaten many populations of people especially in the USA, the leading country in terms of both deaths and cases. More and more reports show that the spread of COVID-19 involves infected individuals first passing through a pre-symptomatic infectious stage in addition to the incubation period and that many of the infectious individuals are asymptomatic. In this study, we design and use a mathematical model to primarily address the question of who are the main drivers of COVID-19 - the symptomatic infectious or the presymptomatic and asymptomatic infectious in the states of Florida, Arizona, New York, Wisconsin and the entire United States. We emphasize the benefit of lockdown by showing that for all four states, earlier and later lockdown dates decrease the number of cumulative deaths. This benefit of lockdown is also evidenced by the decrease in the infectious cases for Arizona and the entire US when lockdown is implemented earlier. When comparing the influence of the symptomatic infectious versus the presympomatic/asymptomatic infectious, it is shown that, in general, the larger contribution comes from the latter group. This is seen from several perspectives (1) in terms of daily cases, (2) in terms of daily cases when the influence of one group is targeted over the other by setting the effective contact rate(s) for the non-targeted group to zero, and (3) in terms of cumulative cases and deaths for the US and Arizona when the influence of one group is targeted over the other by setting the effective contact rate(s) for the non-targeted group to zero. The consequences of the difference in the contributions of the two infectious groups is simulated in terms of testing and these simulations show that an increase in testing and isolating for the presymptomatic and asymptomatic infectious group has more impact than an increase in testing for the symptomatic infectious. For example, for the entire US, a 50% increase in testing for the presymptomatic and asymptomatic infectious group results in a 35% decrease in deaths as opposed to a lower 6% decrease in deaths when a 50% increase in testing rate for the symptomatic infectious is implemented. We also see that if the testing for infectious symptomatic is kept at the baseline value and the testing for the presymptomatic and asymptomatic is increased from 0.2 to 0.25, then the control reproduction number falls well below 1. On the other hand, to get even close to such a result when keeping the presymptomatic and asymptomatic at baseline fitted values, the symptomatic infectious testing rate must be increased considerably more - from 0.25 to 1.7. Lastly, we use our model to simulate an implementation of a natural herd immunity strategy for the entire U.S. and for the state of Wisconsin (the most recent epicenter) and we find that such a strategy requires a significant number of deaths and as such is questionable in terms of success. We conclude with a brief summary of our results and some implications regarding COVID-19 control and mitigation strategies. The coronavirus, known as COVID-19, emerged in Wuhan, China in December 2019, and has since then 40 spread to all countries on earth. As of 12/10/2020, the United States has reported 15,535,565 cases and 41 291,403 deaths and although the leading country in both deaths and cases, the U.S. did not implement a 42 national pandemic control initiative. Instead, many states and cities implemented their own initiatives at 43 various times, and the transmission of COVID-19 has varied from state to state. States also implemented 44 1 Email: Kamal.Barley@stonybrook.edu 2 Email: kcook7@tulane.edu 3 Email: sscott@msri.org, corresponding author 4 This collaboration was sponsored by the ADJOINT 2020 workshop at MSRI through the University of California Berkeley. • If we isolate all symptomatic infectious individuals or all asymptomatic and presymptomatic infectious 91 individuals, how will this impact deaths and cases? (Section 4.3.3) 92 • How might a minimum testing rate for presymptomatic and asymptomatic compare to that for the 93 symptomatic infectious individuals in order to obtain a reproduction number below 1? (section 4.3.4) 94 • How many deaths will occur in a natural herd immunity simulation for Wisconsin and the entire US? 95 (Section 4.4) 96 2.1. In order to assess and deliver guidelines for individuals to avoid coronavirus infection, the CDC has 98 implemented models equipped with the many stages of the virus [1]. A person who has been infected is 99 considered pre-symptomatic (an individual who is infectious but did not show symptoms at the time of We are interested in modeling COVID-19 in the United States as a whole, as well as focusing on four 109 states. We consider New York (Northeast), which started as an epicenter in the US. We consider Florida 110 (Southeast) and Arizona (Southwest) due to the fact that they became hot spots with significant numbers of 111 daily cases and overwhelming numbers in their healthcare facilities. Lastly, we consider Wisconsin (Midwest), 112 which became a hot spot later in the year. Table 1 shows the differences between the states with regards to 113 the number of cumulative deaths. Cumulative Deaths Beginning of lockdown End of lockdown on August 11, 2020 on November 23, 2020 United States 16767 104803 164519 257779 Arizona 25 651 4199 6464 Florida 170 1399 8553 18085 New York 249 30482 32770 34339 Wisconsin 10 594 1006 3158 3 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 4, 2021. ; 116 We use a modified Kermack-McKendrik-type epidemic (no human demography) model to better under-117 stand the dynamics of COVID-19. Since a main objective of this study is to analyze the role of infectious 118 individuals who show no symptoms, the model (2) includes a presymptomatic compartment as the foundation 119 for parameter estimation. We use a deterministic susceptible, exposed, presymptomatic, symptomatically-120 infectious, asymptomatically-infectious, self-isolated, hospitalized, recovered, and ICU patients modeling 121 framework, with the classes denoted as S(t), E(t), E P (t), I(t), A(t), J(t), H(t), R(t),C(t) respectively; 122 we also include D(t) to track deaths.The model also includes the mitigation/control interventions of face 123 mask usage (with a compliance parameter as well as a face mask efficacy parameter) and testing/detection 124 implementation for each of the infectious classes. We obtain the observed cumulative deaths and cases data for the states of Arizona, Florida, New York 127 and Wisconsin from the COVID-19 Data Repository by the Center for Systems Science and Engineering 128 (CSSE) at Johns Hopkins University (2020). The repository contains data beginning at January 22, 2020 129 (the marked beginning of the pandemic in the US), however, we focus primarily on the data from March 1, 130 2020 through October 13, 2020. Using these data sets we determine the initial conditions for the number of 131 cases and deaths for a given time period. The model has 24 parameters and we use values from the literature for 18 of these and estimate the 133 remaining 6 by fitting the model to the observed cumulative mortality data for each state. The parameters 134 that are estimated are as follows: the effective contact rate for the symptomatically-infectious individuals β I , 135 the effective contact rate for the asymptomatically-infectious individuals β A , the effective contact rate for 136 presymptomatically-infectious individuals β P , the rate at which presympotomatically-infectious individuals 137 self-isolate τ P , the rate at which asympotomatically-infectious individuals self-isolate τ A , and the hospitaliza-138 tion rate for self-isolating individuals α J . Parameter fitting was performed using a non-linear sum-of-squares CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 4, 2021. ; The basic reproduction number R 0 is the average number of secondary infections produced when one infected individual is introduced into a host population of susceptibles. For our model's R 0 , we have R 0 = The control reproduction number R C is the average number of new cases generated by a typical infectious 158 individual introduced into a host population of susceptibles with some control measures/interventions in 159 place. Using the next generation operator method and notation found in [12] we have the following compu- . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2020.12.28.20248967 doi: medRxiv preprint R C is the spectral radius of the next generation matrix given by, . In absence of interventions, and unstable if R C > 1. A basic implication of Theorem 1 is that in order to control the COVID-19 outbreak (to not generate 169 more), it suffices to keep R C < 1. We analyze how well our model fits the data from John Hopkins using the T-Test in R. The T-Test measures the difference between two sets of continuous data. We want to compare two sample means to determine if there is a statistically significant difference between the model and the data. We use a paired T-test where each vector has the same amount of entries and the values are taken from the same independent variable. The T-Test assumes that the data in each vector is normally distributed and that they have approximately equal variances. To test for normality, we use the Shapiro-Wilk Test in R. The null hypothesis for this test is that the values in the vector are normally distributed. If the p-value is greater than 0.05, then the distribution of the values in the vector are not significantly different from the normal distribution. I.e. we fail to reject the null hypothesis. We can visualize this using a Q-Q plot. We assume normality if all the points fall along the reference line. We then check the variances of the values in the two vectors using the standard variance equation from probability. Let the null hypothesis for the T-Test be that the difference between the two groups is 0. The T-statistic is defined as . We conclude that the model for each state, cumulative death population, during the lockdown period 172 does indeed fit the data. 6 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2020.12.28.20248967 doi: medRxiv preprint York over the pre-lockdown, lockdown, and post-lockdown periods based on the state's respective decisions. to May 28, 2020, as given in [10] . The post-lockdown periods begin at the end of the prescribed lockdown 184 period for each state and for most of our results ends on August 11, 2020. Figure 3 shows the fit for our 185 model with the cumulative deaths data during the lockdown period. The state variables and the parameters for our model are given in the Appendix in Tables 3 and 4 188 respectively. In general, an earlier lockdown also results in a decrease in daily cases for both the symptomatic and CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2020.12.28.20248967 doi: medRxiv preprint On the other hand, if we use the original lockdown start dates but extend the lockdown periods by 2 and 200 4 weeks for each state, we again see a decrease in cumulative deaths as shown in Figure 6 . is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2020.12.28.20248967 doi: medRxiv preprint The parameter β I represents the contacts by the symptomatically infectious individuals that could trans-214 mit the disease. By setting β I = 0, we eliminate that transmission and focus on the effect of the presymp-215 tomatic and asymptomatic individuals. Similarly, fixing β A = β P = 0, targets the effect of the symptomat-216 ically infectious. In order to further discern the role of the asymptomatic and presymptomatic infectious 217 versus that of the symptomatic infectious, we consider these zero contact rate scenarios in terms of the num-218 ber of daily cases for all of the states and the entire U.S. In Figure 9 , we show the results for the pre-lockdown 219 and post-lockdown periods and for those periods, we again get that the larger contribution comes from the 220 asymptomatic and presymptomatic individuals. For the lockdown period we obtain mixed results and these 221 are considered in the appendix (Figure 16 ). CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2020.12.28.20248967 doi: medRxiv preprint Figure 9 : The plots show the daily cases for each state with β I = 0 (cyan curve) and with β A = β P = 0 (red curve) during their respective Row 1: Pre-lockdown period and Row 2: Post-lockdown period. In Figure 10 , we again take the β I = 0 (green curve) versus the β A = β P = 0 (magenta curve) scenario, but Figure 10 : The cumulative cases and deaths for the U.S. and Arizona over the respective lockdown period where Case 1 corresponds to β I = 0 (green curve; so focuses on the impact of asymptomatic/pre-symptomatic individuals) and Case 2 corresponds to β A = β P = 0 (magenta curve; so focuses on the impact of symptomatic individuals) Recall that the τ values give the rate for testing/detection of infected individuals and subsequent self-228 isolation. In this section we compare and contrast the effect of isolating the symptomatic against the effect 229 of isolating the asymptomatic and presymptomatic by changing the appropriate τ values. For example, to 230 address the effect of isolating symptomatic infectious individuals, we can increase the value of τ I (the rate 231 that symptomatically infectious individuals self-isolate) while keeping all other rates the same. We consider 232 this scenario for the entire U.S. and find that when τ I increases (so that the number of symptomatically 233 infectious individuals that are self-isolated and taken out of the general population increases), the number of 234 cumulative deaths decreases by as much as 12.5%. Alternatively, if the rate of self-isolation for the asymp-235 tomatic and presymptomatic infectious individuals -τ A and τ P respectively -are increased and the τ I is kept 236 at the baseline value for the U.S., the number of cumulative deaths decreases by about 35% at the end of the 237 period -see Figure 11 . Thus, the decrease is more pronounced when the τ A and τ P are increased than when 238 the τ I is increased which indicates that the asymptomatic and presymptomatic have more impact. Figure 239 12 focuses on the difference in impact with 50% increase in testing and shows that the asmptomatic and 240 10 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 4, 2021. ; presymptomatic testing gives up to about four times as much percent decrease as the symptomatic. We can also compare the effect of these type of testing scenarios for different states. For example, 243 although Wisconsin and Florida had similar testing rates around 12/10/2020, we find that a 50% increase 244 in τ A and τ P , results in roughly a 20% decrease in cumulative deaths for Wisconsin compared to a 50% 245 decrease in cumulative deaths for Florida - Figure 13 . Note that the results for both states show the greater 246 influence of the aysmptomatic and presymptomatic infectious. In this section we consider the question concerning the minimum rate of testing/detection required to 249 lower the control reproduction number, R C below one. This question is more difficult to answer directly, 250 but we can begin to get at an answer by again considering the effect of increasing testing. For example, for 251 the entire U.S. from May 28 to Aug 11 (after lifting of lockdown) if the testing is ramped up to the rate of 252 11 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2020.12.28.20248967 doi: medRxiv preprint 0.2 for asymptomatic and presymptomatic -that is, if τ A and τ P are both set to 0.2, while τ I = 0.25, then 253 the reproduction control number R C is 0.9819 (so just below 1). If τ A and τ P are bumped above 0.2, for 254 example to 0.25, while τ I remains at 0.25, then R C falls well below 1 -to 0.8858 -and the resulting decrease 255 in cumulative deaths and daily cases is shown in Figure 14 . To get a better appreciation of the impact of 256 testing for asymptomatic and presymptomatic cases, note that if τ A and τ P are kept at their baseline fitted 257 values, then τ I must be increased to 1.7 to get R C = 0.9119. Of course, the challenge with all of these 258 testing scenarios is that the testing of asymptomatic and presymptomatic individuals is more difficult since 259 those individuals do not have symptoms, so in order to achieve these testing rates, widespread and frequent 260 testing should be implemented. Natural herd immunity refers to the process by which enough of the population achieves immunity 264 via natural recovery from the disease, so that the remaining population that is not immune also receives 265 protection against the acquisition of the disease. The process involves a natural herd immunity threshold, 266 that is, the minimum number of people required to achieve disease-acquired immunity. For a disease with 267 a basic reproduction number of R 0 , the necessary minimum fraction of people who must achieve immunity 268 can be given as 1 − 1/R 0 . We simulate for both Wisconsin (a state which was considered an epicenter later 269 in 2020) and the entire U.S., a scenario in which COVID-19 is allowed to run its natural course (with no 270 implementation of any new control or mitigation strategies) until natural herd immunity is achieved . For 271 both Wisconsin and the entire US, the number of deaths that occur before reaching the herd immunity 272 threshold, is considerably high; thus, making the success of a natural herd immunity strategy for COVID-19 273 questionable (at the very least). For the state of Wisconsin, the number of deaths that occurs is approximately 274 450,000 and for the entire U.S., the number of deaths is more than 10 million -see Figure 15 . . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2020.12.28.20248967 doi: medRxiv preprint From various perspectives, our analysis indicates that overall, the drivers of COVID-19 are the asymp-277 tomatic and presymptomatic infectious individuals. We see that if testing is increased, these asymptomatic 278 and presymptomatic infectious have a greater impact than the symptomatic infectious; hence, widespread 279 and frequent testing is key to controlling the spread of the disease. This is especially true after holiday 280 periods and large gathering events which are often notorious for reduced and lax implementation of control 281 and mitigation strategies such as social distancing. Thus, in the schools and workplaces, testing should be 282 intentionally and systematically increased after such occurrences in order to control the silent transmission 283 by the newly infectious individuals who do not (yet) have symptoms. Our simulations also show that al-284 though lockdown might be difficult in terms of economic impact, the benefit of even a short lockdown (2 285 weeks) in reducing deaths is considerable. 13 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 4, 2021. Wisconsin we get more symptomatic infectious cases than asymptomatic and presymptomatic -see Figure 294 16. 295 Figure 16 : The plots show the daily cases for each state with β I = 0 (cyan curve) and β A = β P = 0 (red curve) for the lockdown period. In this section, we show the plots for the goodness of fit of the lockdown period for each state and the 297 US as a whole. 14 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 4, 2021. ; . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2020.12.28.20248967 doi: medRxiv preprint The authors thank MSRI and the AJOINT program for their continued support. 300 16 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2020.12.28.20248967 doi: medRxiv preprint Covid-19 dashboard by the center for systems science and engineering Covid-19 statistics Sus-308 tainable social distancing through facemask use and testing during the covid-19 pandemic. medRxiv To mask or not to mask: Modeling the potential for face mask use 312 by the general public to curtail the covid-19 pandemic Using mathematics to understand covid-19 314 dynamics. Notices of the Effectiveness of isolation, testing, contact tracing, and physical distancing 318 on reducing transmission of sars-cov-2 in different settings: a mathematical modelling study. The Lancet 319 Infectious Diseases Mathematical assessment of the impact of non-pharmaceutical 322 interventions on curtailing the 2019 novel coronavirus Gumel Abba B. Ngonghala, Calistus. Could masks curtail the post-lockdown 324 resurgence of COVID-19 in the US? An orally bioavailable broad-spectrum antiviral inhibits sars-cov-2 in 326 human airway epithelial cell cultures and multiple coronaviruses in mice Reproduction numbers and sub-threshold endemic equilibria 329 for compartmental models of disease transmission Estimation of effects of contact tracing and mask adoption on covid-19 transmission in san francisco: a 332 modeling study. medRxiv